Palynziq
Active substance: pegvaliase
INJECTION, SOLUTION · PEGVALIASE 2.5 mg/.5mL
United StatesActive
Marketing holder: BioMarin Pharmaceutical Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PEGVALIASE · 2.5 mg/.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-9608-7859-8448-ed62a568e694,01a12094-6aa8-7418-a05b-6dbc3ac944c8,01a12096-f566-703e-b017-0ada80ed25db;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68135-058
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 68135-058 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68135-058 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68135-058 · Verified 2026-10-09 · open in source